David Wang
Private Equity Investor bij OrbiMed Advisors Private Equity
Oorsprong van het eerstegraads netwerk van David Wang
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
90
| Subsidiary | Investment Managers | 90 |
Three Arch Partners
 Three Arch Partners Investment ManagersFinance Three Arch Partners (TAP) is a venture capital firm founded in 1993 by Thomas Fogarty and Wilfred Jaeger. The firm is headquartered in San Mateo, California.
10
| Private Company | Investment Managers | 10 |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA.
2
| Subsidiary | Medical Specialties | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Wang via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Chief Executive Officer Founder Founder Portfolio Manager-Equities Analyst-Equity Private Equity Investor Private Equity Investor Portfolio Manager-Equities Analyst-Equity Portfolio Manager-Fixed Income Trading-Equity Portfolio Manager-Equities | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Founder Director/Board Member Director of Finance/CFO | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Medical Specialties | Director/Board Member Chairman Director/Board Member Director of Finance/CFO | |
| XTANT MEDICAL HOLDINGS, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO | |
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Investment Managers | Private Equity Analyst Founder Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal Corporate Officer/Principal | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
| XYLO TECHNOLOGIES LTD | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| GELESIS INC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Private Equity Analyst Comptroller/Controller/Auditor | |
| CHEMOMAB THERAPEUTICS LTD. | Biotechnology | Chairman Chairman | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Santa Clara University | College/University | Undergraduate Degree Masters Business Admin | |
| SCULPTOR CAPITAL MANAGEMENT, INC. | Investment Managers | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Ornim Medical, Inc. | Director/Board Member Director/Board Member | ||
| Yale University | College/University | Graduate Degree Doctorate Degree | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NEUROPACE, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| FORTRESS INVESTMENT GROUP LLC | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Founder | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Biotechnology | Chairman Director/Board Member | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Israël | 6 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 10 |
Operationeel
| Director/Board Member | 488 |
| Corporate Officer/Principal | 119 |
| Independent Dir/Board Member | 110 |
| Private Equity Investor | 108 |
| Undergraduate Degree | 93 |
Sterkste connecties
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Jonathan Silverstein | 42 |
| Stephen P. Squinto | 40 |
| Peter Thompson | 39 |
| Nancy T. Chang | 31 |
| Iain Dukes | 30 |
| Erez Chimovits | 30 |
| Rishi Gupta | 29 |
| Sunny Sharma | 29 |
| David Bonita | 27 |
| Guo-Liang Yu | 27 |
| Nissim Darvish | 27 |
| Steve Yecies | 23 |
| Dina Chaya | 23 |
| Sheila Gujrathi | 20 |
- Beurs
- Insiders
- David Wang
- Bedrijfsconnecties
